CS logo
small CS logo
McMaster Institute of Urology

Hamilton, Ontario, Canada
Urologist in Hamilton, Ontario
50 Charlton Ave E, Hamilton, ON L8N 4A6

About McMaster Institute of Urology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at McMaster Institute of Urology


During the past decade, McMaster Institute of Urology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII
2007-12-01
2018-04-01
Completed
66
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q
2010-01-26
2018-05-09
Completed
239
LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy
2012-03-05
2017-12-27
Completed
795
Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)
2013-09-25
2019-11-14
Completed
267
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Safety of Dabigatran Etexilate in Blood Clot Prevention in Children
2014-09-29
2019-11-19
Completed
214
Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)
2017-12-15
2020-11-09
Completed
154

Rows per page:

1–14 of 14

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "McMaster Institute of Urology" #1 sponsor was "St. Joseph's Healthcare Hamilton" with 6 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Abbott" with 3 trials sponsored, "Pfizer" with 2 trials sponsored and "Canadian Urology Research Consortium" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "McMaster Institute of Urology" #1 collaborator was "Ferring Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at McMaster Institute of Urology


According to Clinical.Site data, the most researched conditions in "McMaster Institute of Urology" are "Prostatic Neoplasms" (3 trials), "Overactive Bladder" (2 trials), "Prostate Cancer" (2 trials), "Adenocarcinoma" (1 trials) and "Benign Prostatic Hyperplasia" (1 trials). Many other conditions were trialed in "McMaster Institute of Urology" in a lesser frequency.

Clinical Trials Intervention Types at McMaster Institute of Urology


Most popular intervention types in "McMaster Institute of Urology" are "Drug" (11 trials), "Procedure" (4 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atrasentan" (3 trials), "Placebo" (3 trials), "Niraparib" (2 trials), "Prednisone" (2 trials) and "Abiraterone Acetate" (1 trials). Other intervention names were less common.

Clinical Trials Genders at McMaster Institute of Urology


The vast majority of trials in "McMaster Institute of Urology" are 10 trials for "Male" genders and 6 trials for "All" genders.

Clinical Trials Status at McMaster Institute of Urology


Currently, there are NaN active trials in "McMaster Institute of Urology". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in McMaster Institute of Urology, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in McMaster Institute of Urology, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status